Using Cardiac Magnetic Resonance Imaging to Evaluate Patients with Chest Pain in the Emergency Department
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Chest pain is one of the most common presenting symptoms in the emergency department (ED). Among patients with abnormal troponins, it is imperative to quickly and accurately distinguish type 1 acute myocardial infarction (AMI) from other etiologies of myocardial injury. Although high-sensitivity troponin assays introduced a high negative predictive value for AMI, they have exposed the need for diagnostic modalities that can determine the etiology of acute myocardial injury. Cardiac magnetic resonance imaging (CMR) is an effective tool to risk stratifying chest pain among patients in the ED. CMR is non-invasive and has a lower cost of care and shorter length of stay compared to those of invasive coronary angiography. It also provides detailed information on cardiac morphology, function, tissue edema, and location and pattern of tissue damage that can help to differentiate many etiologies of cardiac injury. CMR is particularly useful to distinguish chest pain due to type 1 AMI versus supply-demand mismatch due to acute cardiac noncoronary artery disease. A detailed review of the literature has shown that CMR with stress testing is safe to use in patients presenting to the ED with chest pain, with or without abnormal troponins. CMR is a useful, safe, economical, and effective alternative to the traditional diagnostic tools that are typically used in this patient population. It is a practical tool to risk-stratify patients with possible cardiac pathology and to clarify diagnosis without invasive testing.
Abstract
Chest pain is one of the most common presenting symptoms in the emergency department (ED). Among patients with abnormal troponins, it is imperative to quickly and accurately distinguish type 1 acute myocardial infarction (AMI) from other etiologies of myocardial injury. Although high-sensitivity troponin assays introduced a high negative predictive value for AMI, they have exposed the need for diagnostic modalities that can determine the etiology of acute myocardial injury. Cardiac magnetic resonance imaging (CMR) is an effective tool to risk stratifying chest pain among patients in the ED. CMR is non-invasive and has a lower cost of care and shorter length of stay compared to those of invasive coronary angiography. It also provides detailed information on cardiac morphology, function, tissue edema, and location and pattern of tissue damage that can help to differentiate many etiologies of cardiac injury. CMR is particularly useful to distinguish chest pain due to type 1 AMI versus supply-demand mismatch due to acute cardiac noncoronary artery disease. A detailed review of the literature has shown that CMR with stress testing is safe to use in patients presenting to the ED with chest pain, with or without abnormal troponins. CMR is a useful, safe, economical, and effective alternative to the traditional diagnostic tools that are typically used in this patient population. It is a practical tool to risk-stratify patients with possible cardiac pathology and to clarify diagnosis without invasive testing.
참고문헌 (37)
- National Hospital Ambulatory Medical Care Survey: 2017 Emergency Department Summary Tables, "Rui PK", National Center for Health Statistics, ~ (2017)
- Reichlin T, "Early diagnosis of myocardial infarction with sensitive cardiac troponin assays", N Engl J Med, 361, pp.858~867 (2009)
- Shah AS, "Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study", BMJ, 359, pp.j4788~ (2017)
- Haaf P, "High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease", Circulation, 126, pp.31~40 (2012)
- McNamara RL, "International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP", NICOR, SWEDEHEART, NCDR registries, pp.Int J Cardiol, 2014[DOI]
- Kimenai DM, "Sex-specific effects of implementing a high-sensitivity troponin I assay in patients with suspected acute coronary syndrome : results from SWEDEHEART registry", Sci Rep, 10, pp.15227~ (2020)
- Yousuf T, "Impact of chest pain protocol targeting intermediate cardiac risk patients in an observation unit of an academic tertiary care center", J Clin Med Res, 8, pp.111~115 (2016)
- Agewall S, "ESC working group position paper on myocardial infarction with non-obstructive coronary arteries", Eur Heart J, 38, pp.143~153 (2017)
- Kim RJ, "Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial", Circulation, 117, pp.629~637 (2008)
- Thygesen K, "Fourth universal definition of myocardial infarction (2018)", Circulation, 138, pp.e618~e651 (2018)
- Yilmaz A, "Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis", Heart, 94, pp.1456~1463 (2008)
- Agewall S, "Troponin elevation in coronary vs. non-coronary disease", Eur Heart J, 32, pp.404~411 (2011)
- Callan PD, "Acute fulminant necrotizing eosinophilic myocarditis : early diagnosis and treatment", ESC Heart Fail, 4, pp.660~664 (2017)
- Greulich S, "CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis", JACC Cardiovasc Imaging, 6, pp.501~511 (2013)
- Dong Y, "A novel simple scoring model for predicting severity of patients with SARS-CoV-2 infection", Transbound Emerg Dis, 67, pp.2823~2829 (2020)
- Plácido R, "The role of cardiovascular magnetic resonance in takotsubo syndrome", J Cardiovasc Magn Reson, 18, pp.68~ (2016)
- Morrow DA, "Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial", Eur Heart J, 40, pp.3345~3352 (2019)
- Mahrholdt H, "Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies", Eur Heart J, 26, pp.1461~1474 (2005)
- Ricciardi MJ, "Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation", Circulation, 103, pp.2780~2783 (2001)
- Katz G, "Elevated cardiac troponin T in patients with lupus myositis presenting with noncardiac chest pain", Case Rep Rheumatol, 2020, pp.8884759~ (2020)
- Amsterdam EA, "2014 AHA", ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology, Circulation, pp.2014, 130[DOI]
- Fox KA, "Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome : prospective multinational observational study(GRACE)", BMJ, 333, pp.1091~ (2006)
- Antman EM, "The TIMI risk score for unstable angina", non-ST elevation MI : a method for prognostication and therapeutic decision making, 2000, pp.284, 835~842
- Rybicki FJ, "2015 ACR", ACC, AATS, pp.ACEP, ASNC[DOI]
- Mahaffey KW, "Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial", J Am Coll Cardiol, 34, pp.1711~1720 (1999)
- Cerqueira MD, "Safety profile of adenosine stress perfusion imaging : results from the Adenoscan Multicenter Trial Registry", J Am Coll Cardiol, 23, pp.384~389 (1994)
- Gibbons RJ, "ACC", AHA 2002 guideline update for exercise testing : summary article : a report of the American College of Cardiology, Circulation, pp.2002, 106[DOI]
- Heitner JF, "Stress cardiac MR imaging compared with stress echocardiography in the early evaluation of patients who present to the emergency department with intermediate-risk chest pain", Radiology, 271, pp.56~64 (2014)
- Ingkanisorn WP, "Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain", J Am Coll Cardiol, 47, pp.1427~1432 (2006)
- Kwong RY, "Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging", Circulation, 107, pp.531~537 (2003)
- Lerakis S, "Prognostic value of adenosine stress cardiovascular magnetic resonance in patients with low-risk chest pain", J Cardiovasc Magn Reson, 11, pp.37~ (2009)
- Miller CD, "Stress CMR reduces revascularization, hospital readmission, and recurrent cardiac testing in intermediate-risk patients with acute chest pain", JACC Cardiovasc Imaging, 6, pp.785~794 (2013)
- Plein S, "Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging", J Am Coll Cardiol, 44, pp.2173~2181 (2004)
- Smulders MW, "Initial imaging-guided strategy versus routine care in patients with non-ST-segment elevation myocardial infarction", J Am Coll Cardiol, 74, pp.2466~2477 (2019)
- Steen H, "Staged cardiovascular magnetic resonance for differential diagnosis of troponin T positive patients with low likelihood for acute coronary syndrome", J Cardiovasc Magn Reson, 12, pp.51~ (2010)
- Starling MR, "Treadmill exercise tests predischarge and six weeks post-myocardial infarction to detect abnormalities of known prognostic value", Ann Intern Med, 94, pp.721~727 (1981)
- Laureano-Phillips J, "HEART score risk stratification of low-risk chest pain patients in the emergency department : a systematic review and meta-analysis", Ann Emerg Med, 74, pp.187~203 (2019)